Morgan Stanley's Schedule 13G Filing for Evoke Pharma Inc

Morgan Stanley and Morgan Stanley Smith Barney LLC have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 10.5% of the common stock of Evoke Pharma Inc. The filing indicates that the shares are held in the ordinary course of business and not for the purpose of influencing control of the issuer. The filing includes a joint filing agreement and item 7 information as exhibits. The shares are held by Morgan Stanley as a holding company and Morgan Stanley Smith Barney LLC as a broker-dealer and investment advisor. The filing is made pursuant to Rule 13d-1(b) and is signed by authorized signatories from both entities.